mRNA therapeutic successfully combats ovarian cancer in mice

Each year, several thousand women in Germany die from ovarian cancer. In many cases, the disease is only detected when it is very advanced and metastases have already formed—usually in the intestines, abdomen or lymph nodes. At such a late stage, only 20% to 30% of all those affected survive the next five years.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart